Consistent with ACCP’s commitment to excellence in science and education, the 2017 ACCP Annual Meeting Program Committee, co-chaired by Drs. Catherine Sherwin and Gilbert Burckart, has worked diligently to provide a diverse and exceptional educational program that meets the needs of healthcare professionals and scientists with an interest in one or more of the myriad of applications of clinical pharmacology ranging from research and drug development to patient care. Speakers spanning the breadth of academia, industry, regulatory agencies, consulting companies and clinical specialties will present educational and scientific programs organized into topic tracks that allow attendees to uniquely tailor content selection to their individual interests.
On Saturday, September 16th, four Pre-meeting Workshops will cover topics such as the labeling of off-patent medications for pediatric use, perspectives on physiologically-based pharmacokinetic modeling for labeling initiatives, therapeutic drug monitoring in advancing patient care and strategies for dose selection of therapies used in different areas of oncology. The 3-Day meeting will begin with a Plenary Session on Predicting Pharmacokinetics/Pharmacodynamics in the Individual Patient: Separating Reality from Hype and continue with a mixture of several shorter Symposia combined with our traditional four-hour educational format. Major clusters of topic areas include: drug development, pediatrics, pharmacometrics & clinical applications. Invited Keynote will be William E. Evans, PharmD, Faculty Member, Endowed Chair in Pharmacogenomics, St Jude Children’s Research Hosp.
A series of special Student, Trainee & Young Professional-focused programs are planned that provide exposure to innovative science and career development opportunities.
Poster Sessions held on Sunday and Monday evening will focus on new findings and preliminary data presented by a wide spectrum of attendees.